Patents by Inventor Mary Ya-Ping Yeh

Mary Ya-Ping Yeh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of detecting a urine protein fragment and a serum protein fragment
    Patent number: 10101340
    Abstract: Described is a method of detecting a protein fragment in a urine sample and a serum sample. The protein fragment is a urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, or serum osteopontin fragment. The urine sample and the serum sample are obtained from the same individual.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: October 16, 2018
    Assignee: Bio Preventive Medicine Corp.
    Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
  • Biomarkers associated with nephropathy
    Patent number: 9442120
    Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: September 13, 2016
    Assignee: Industrial Technology Research Institute
    Inventors: Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Mary Ya-Ping Yeh, Yi-Ting Chen, Chwei-Shiun Yang
  • BIOMARKERS ASSOCIATED WITH NEPHROPATHY
    Publication number: 20130266976
    Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.
    Type: Application
    Filed: June 7, 2013
    Publication date: October 10, 2013
    Inventors: Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Mary Ya-Ping Yeh, Yi-Ting Chen, Chwei-Shiun Yang
  • URINE AND SERUM BIOMARKERS ASSOCIATED WITH DIABETIC NEPHROPATHY
    Publication number: 20130252267
    Abstract: Described are uses of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.
    Type: Application
    Filed: May 24, 2013
    Publication date: September 26, 2013
    Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
  • Urine and serum biomarkers associated with diabetic nephropathy
    Patent number: 8476077
    Abstract: Disclosed is use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.
    Type: Grant
    Filed: December 15, 2010
    Date of Patent: July 2, 2013
    Assignee: Industrial Technology Research Institute
    Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
  • Biomarkers associated with nephropathy
    Patent number: 8470547
    Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.
    Type: Grant
    Filed: December 16, 2010
    Date of Patent: June 25, 2013
    Assignee: Industrial Technology Research Institute
    Inventors: Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Mary Ya-Ping Yeh, Yi-Ting Chen, Chwei-Shiun Yang
  • Urine and serum biomarkers associated with diabetic nephropathy
    Patent number: 8465980
    Abstract: Disclosed is use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.
    Type: Grant
    Filed: January 27, 2010
    Date of Patent: June 18, 2013
    Assignee: Industrial Technology Research Institute
    Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
  • BIOMARKERS ASSOCIATED WITH NEPHROPATHY
    Publication number: 20110086372
    Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.
    Type: Application
    Filed: December 20, 2010
    Publication date: April 14, 2011
    Applicant: Industrial Technology Research Institute(ITRI)
    Inventors: Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Yi-Ting Chen, Chwei-Shiun Yang
  • URINE AND SERUM BIOMARKERS ASSOCIATED WITH DIABETIC NEPHROPATHY
    Publication number: 20110086371
    Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.
    Type: Application
    Filed: December 20, 2010
    Publication date: April 14, 2011
    Applicant: Industrial Technology Research Institute(ITRI)
    Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
  • BIOMARKERS ASSOCIATED WITH NEPHROPATHY
    Publication number: 20110081667
    Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.
    Type: Application
    Filed: December 15, 2010
    Publication date: April 7, 2011
    Applicant: Industrial Technology Research Institute(ITRI)
    Inventors: Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Yi-Ting Chen, Chwei-Shiun Yang
  • BIOMARKERS ASSOCIATED WITH NEPHROPATHY
    Publication number: 20110081668
    Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.
    Type: Application
    Filed: December 16, 2010
    Publication date: April 7, 2011
    Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE(ITRI)
    Inventors: MARY YA-PING YEH, TZU-LING TSENG, CHING-FANG LU, WEI-YA LIN, TSAI-WEI HSU, YI-TING CHEN, CHWEI-SHIUN YANG
  • Urine and Serum Biomarkers Associated with Diabetic Nephropathy
    Publication number: 20110079077
    Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.
    Type: Application
    Filed: December 15, 2010
    Publication date: April 7, 2011
    Applicant: Industrial Technology Research Institute(ITRI)
    Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
  • BIOMARKERS ASSOCIATED WITH NEPHROPATHY
    Publication number: 20100209948
    Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.
    Type: Application
    Filed: January 27, 2010
    Publication date: August 19, 2010
    Applicant: Industrial Technology Research Institute(ITRI)
    Inventors: Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Yi-Ting Chen, Chwei-Shiun Yang
  • URINE AND SERUM BIOMARKERS ASSOCIATED WITH DIABETIC NEPHROPATHY
    Publication number: 20100197033
    Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.
    Type: Application
    Filed: January 27, 2010
    Publication date: August 5, 2010
    Applicant: Industrial Technology Research Institute (ITRI)
    Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li